Orexo AB
F:C5G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
F:C5G
|
SE |
|
AMN Healthcare Services Inc
NYSE:AMN
|
US |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
DSM-Firmenich AG
OTC:DSFIY
|
CH |
|
Q2 Holdings Inc
NYSE:QTWO
|
US |
|
B
|
Banca Mediolanum SpA
OTC:BNMDF
|
IT |
|
Deckers Outdoor Corp
NYSE:DECK
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
XMUN:75C
|
CN |
|
A
|
Alcoa Corp
F:185
|
US |
|
D
|
Davide Campari Milano NV
LSE:0ROY
|
IT |
|
Central Japan Railway Co
TSE:9022
|
JP |
|
Healthcare Realty Trust Inc
F:HT0
|
US |
|
Data Storage Corp
NASDAQ:DTST
|
US |
|
A
|
Adidas AG
LSE:0OLD
|
DE |
|
SEMrush Holdings Inc
F:628
|
US |
|
H
|
Heng Leasing and Capital PCL
SET:HENG
|
TH |
|
C
|
CK Power PCL
SET:CKP
|
TH |
|
P
|
Parsons Corp
F:59P
|
US |
|
U
|
Unisys Corp
SIX:UIS
|
US |
|
V
|
Volkswagen AG
SWB:VOW
|
DE |
|
TFS Financial Corp
NASDAQ:TFSL
|
US |
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
Industrias Penoles SAB de CV
F:4FO
|
MX |
|
M
|
Mondi PLC
F:KYCA
|
UK |
Bankruptcy Probability
Orexo AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Orexo AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Orexo AB
STO:ORX
|
688m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
554.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
249.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Orexo AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Orexo AB has total debt of 483.8m SEK. This includes both short-term (0 SEK) and long-term (483.8m SEK) debt.
You can find a full breakdown on its Balance Sheet.
